Latest

Latest antiviral News | Page 5

  • Latest antiviral news stories and updates. What is happening today? All recent antiviral news and developments. Live coverage and timeline of antiviral. All you need to know about antiviral.
Covid modelling update 20 July 2022
Top 3 questions – Living with Covid in winter with Professor Alison McMillan
Elucidation of antiviral/innate immune response activation mechanism of hepatokine LECT2
NSW Government steps up Covid support for vulnerable communities
Expanded Eligibility Criteria for Covid Oral Antiviral Treatments
End of free RAT program puts vulnerable people at risk
Covid oral treatment eligibility expanded from 11 July 2022
Coronavirus update for Victoria 7 July
Expanded eligibility for fourth Covid vaccine dose
ATAGI updated recommendations for winter dose of Covid vaccine
Coronavirus update for Victoria 6 July
Coronavirus update for Victoria 1 July
Coronavirus update for Victoria 30 June
Starpharma’s anti-viral nasal spray relaunched in UK
Coronavirus update for Victoria 29 June
Coronavirus update for Victoria 28 June 2022
Lumos Diagnostics secures authorisation for test in Canada
Coronavirus update for Victoria 26 June 2022
Coronavirus update for Victoria 25 June 2022
WHO publishes updated guidance on hepatitis C infection
Coronavirus update for Victoria 24 June
Don’t pump brakes: our COVID strategy must change to reflect reality
New Way to Identify Influenza Virus Lights Up When Specific Virus Targets are Present
Reducing COVID transmission by 20% could save 2,000 Australian lives this year
PAXLOVID Oral Covid treatment available on Pharmaceutical Benefits Scheme from 1 May
WHO recommends highly successful Covid therapy and calls for wide geographical distribution and transparency from originator
Scientists Develop Indoor-active Photocatalyst for Antiviral Coating Against Various Variant Types of Novel Coronavirus SARS-CoV-2
SARS-CoV-2 virus can infect heart’s pacemaker cells
First Participants dosed in ENA Respiratory’s phase 2a study
Targeting viral lung infections two ways
Elevated inflammation persists in immune cells months after mild Covid
WHO updates its treatment guidelines to include molnupiravir
First Covid pill funded through PBS
Existing drug may protect against COVID lung injury
PFIZER: TGA Approves Pfizer’s Novel Covid Oral Treatment in Australia
Covid pill LAGEVRIO approved for use in Australia
NZ secures new Pfizer Covid medicine
South-East Asia: Influenza virus sharing in time of Covid
Expert panel confirms “quality of life” as key focus for Australians living with HIV
Biotron’s BIT225 effective against Covid in animal study
Gates Foundation funding for University to develop low cost manufacturing route to promising Covid therapy Molnupiravir
WHO-Unitaid statement on MPP licensing agreement for molnupiravir
TGA grants provisional determination to Pfizer Australia’s Covid treatment PF-07321332 + ritonavir
Australia secures access to additional Covid treatment
Government must buy Covid treatments now
Liquid Metal Coating Creates Effective Antiviral, Antimicrobial Fabric
10 minute testing device could reduce spread of COVID19 in hospitals
Unusual blue woodlice may help develop new antiviral materials

© 2026 - The National Tribune Australia